<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39328418</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Increased incidence of seronegative autoimmune hepatitis in children during SARS-CoV-2 pandemia period.</ArticleTitle><Pagination><StartPage>1445610</StartPage><MedlinePgn>1445610</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1445610</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2024.1445610</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Seronegative autoimmune hepatitis in children is a rare but potentially severe disease, sometimes requiring liver transplantation. This type of hepatitis may be associated with various immunological and hematological disorders, ranging from isolated lymphopenia to aplastic anemia. Precise pathophysiological mechanisms are still unknown, but the role of viruses cannot be excluded, either as directly pathogenic or as triggers, responsible for an inappropriate immune stimulation. Having the impression of an increasing number of seronegative autoimmune hepatitis since the beginning of SARS-CoV-2 pandemia period, we hypothesized that SARS-CoV-2 virus could be an infectious trigger.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We conducted a retrospective, observational, descriptive study about children with seronegative autoimmune hepatitis, in a tertiary care center, between 2010 and 2022.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Thirty-two patients were included. The overall incidence of seronegative autoimmune hepatitis increased 3.3-fold in 2020-2022, during the SARS-CoV-2 pandemia period (16 patients in 2.8 years) compared with 2010-2019 the pre pandemia period (16 patients in 9 years). Patients' clinical and biochemical liver characteristics did not differ between the two periods. Hematological damages were less severe during the pandemia period. Immunological studies revealed a dysregulated immune response. The initiation of immunosuppressive therapy (corticosteroids ± cyclosporine) was earlier during the pandemia period than before.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">In cases of undetermined acute hepatitis, an immune-mediated origin should be considered, prompting a liver biopsy. If the histological aspect points to an immune origin, immunosuppressive treatment should be instituted even though autoimmune hepatitis antibodies are negative. Close hematological monitoring must be performed in all cases. The 3.3-fold increase of cases during the SARS-CoV-2 pandemia will need to be further analyzed to better understand the underlying immunological mechanisms, and to prove its potential involvement.</AbstractText><CopyrightInformation>Copyright © 2024 Schmutz, Chartier, Leblanc, Mussini, Gardin, Gonzales, Roque-Afonso, Le Cam, Hery, Neven, Charbel, Vartanian, Jacquemin, Morelle and Almes.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schmutz</LastName><ForeName>Muriel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Pediatric Hepatology and Pediatric Liver Transplant Department, Reference Center for Biliary Atresia and Genetic Cholestasis, FSMR FILFOIE, European Reference Networks (ERN) RARE LIVER, AP-HP, Paris-Saclay University, Bicêtre Hospital, Kremlin-Bicêtre, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chartier</LastName><ForeName>Suzanne</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Pathology Department, AP-HP, Paris-Saclay University, Bicêtre Hospital, Kremlin-Bicêtre, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leblanc</LastName><ForeName>Thierry</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Pediatric Hematology and Immunology, AP-HP, Université Paris Cité Paris, Robert Debré Hospital, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mussini</LastName><ForeName>Charlotte</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Pathology Department, AP-HP, Paris-Saclay University, Bicêtre Hospital, Kremlin-Bicêtre, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gardin</LastName><ForeName>Antoine</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Pediatric Hepatology and Pediatric Liver Transplant Department, Reference Center for Biliary Atresia and Genetic Cholestasis, FSMR FILFOIE, European Reference Networks (ERN) RARE LIVER, AP-HP, Paris-Saclay University, Bicêtre Hospital, Kremlin-Bicêtre, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>INSERM Unité Mixte de Recherche (UMR)-S 1193, Paris-Saclay University, Hépatinov, Orsay, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>European Reference Networks (ERN) Rare Liver, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonzales</LastName><ForeName>Emmanuel</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Pediatric Hepatology and Pediatric Liver Transplant Department, Reference Center for Biliary Atresia and Genetic Cholestasis, FSMR FILFOIE, European Reference Networks (ERN) RARE LIVER, AP-HP, Paris-Saclay University, Bicêtre Hospital, Kremlin-Bicêtre, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>INSERM Unité Mixte de Recherche (UMR)-S 1193, Paris-Saclay University, Hépatinov, Orsay, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>European Reference Networks (ERN) Rare Liver, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roque-Afonso</LastName><ForeName>Anne-Marie</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>INSERM Unité Mixte de Recherche (UMR)-S 1193, Paris-Saclay University, Hépatinov, Orsay, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Virology Department, National Reference Center for Hepatitis A virus, Paul Brousse Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Villejuif, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le Cam</LastName><ForeName>Solene</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Pediatric Radiology Department, AP-HP, Paris-Saclay University, Bicêtre Hospital, Kremlin-Bicêtre, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hery</LastName><ForeName>Geraldine</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Paediatric Surgery, AP-HP, Paris-Saclay University, Bicêtre Hospital, Kremlin-Bicêtre, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neven</LastName><ForeName>Benedicte</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Pediatric Hematology-Immunology and Rheumatology Department, AP-HP, Université Paris Cité Paris, Necker-Children's Hospital, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>INSERM Unité Mixte de Recherche (UMR) 1163, Imagine Institute, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Charbel</LastName><ForeName>Ramy</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Pediatric Intensive Care Unit, AP-HP, Paris-Saclay University, Bicêtre Hospital, Kremlin-Bicêtre, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vartanian</LastName><ForeName>Jean-Pierre</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Virus and Cellular Stress Unit, Department of Virology, Institut Pasteur, Université de Paris Cité, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacquemin</LastName><ForeName>Emmanuel</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Pediatric Hepatology and Pediatric Liver Transplant Department, Reference Center for Biliary Atresia and Genetic Cholestasis, FSMR FILFOIE, European Reference Networks (ERN) RARE LIVER, AP-HP, Paris-Saclay University, Bicêtre Hospital, Kremlin-Bicêtre, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>INSERM Unité Mixte de Recherche (UMR)-S 1193, Paris-Saclay University, Hépatinov, Orsay, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>European Reference Networks (ERN) Rare Liver, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morelle</LastName><ForeName>Guillaume</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Centre for Haemophilia and Constitutional Bleeding Disorders, AP-HP, Paris-Saclay University, Bicêtre Hospital, Kremlin-Bicêtre, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatric Emergency, AP-HP, Paris-Saclay University, Bicêtre Hospital, Kremlin-Bicêtre, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Almes</LastName><ForeName>Marion</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Pediatric Hepatology and Pediatric Liver Transplant Department, Reference Center for Biliary Atresia and Genetic Cholestasis, FSMR FILFOIE, European Reference Networks (ERN) RARE LIVER, AP-HP, Paris-Saclay University, Bicêtre Hospital, Kremlin-Bicêtre, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>INSERM Unité Mixte de Recherche (UMR)-S 1193, Paris-Saclay University, Hépatinov, Orsay, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>European Reference Networks (ERN) Rare Liver, Hamburg, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007166">Immunosuppressive Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019693" MajorTopicYN="Y">Hepatitis, Autoimmune</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007166" MajorTopicYN="N">Immunosuppressive Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">aplastic anemia</Keyword><Keyword MajorTopicYN="N">dysimmunity</Keyword><Keyword MajorTopicYN="N">immunosuppressive treatment</Keyword><Keyword MajorTopicYN="N">pediatric seronegative autoimmune hepatitis</Keyword><Keyword MajorTopicYN="N">severe acute respiratory syndrome coronavirus 2</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>7</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>7</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>5</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39328418</ArticleId><ArticleId IdType="pmc">PMC11425678</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2024.1445610</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Maggiore G, Socie G, Sciveres M, Roque-Afonso AM, Nastasio S, Johanet C, et al. . Seronegative autoimmune hepatitis in children: Spectrum of disorders. Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver. (2016) 48:785–91. doi: 10.1016/j.dld.2016.03.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dld.2016.03.015</ArticleId><ArticleId IdType="pubmed">27079745</ArticleId></ArticleIdList></Reference><Reference><Citation>Molina RA, Katzir L, Rhee C, Ingram-Drake L, Moore T, Krogstad P, et al. . Early evidence of bone marrow dysfunction in children with indeterminate fulminant hepatic failure who ultimately develop aplastic anemia. Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg. (2004) 4:1656–61. doi: 10.1111/j.1600-6143.2004.00559.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-6143.2004.00559.x</ArticleId><ArticleId IdType="pubmed">15367221</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadžić N, Height S, Ball S, Rela M, Heaton ND, Veys P, et al. . Evolution in the management of acute liver failure-associated aplastic anaemia in children: A single centre experience. J Hepatol. (2008) 48:68–73. doi: 10.1016/j.jhep.2007.08.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2007.08.017</ArticleId><ArticleId IdType="pubmed">17998144</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzakis AG, Arditi M, Whitington PF, Yanaga K, Esquivel C, Andrews WA, et al. . APLASTIC ANEMIA COMPLICATING ORTHOTOPIC LIVER TRANSPLANTATION FOR NON-A, NON-B HEPATITIS. N Engl J Med. (1988) 319:393–6. doi: 10.1056/NEJM198808183190702</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM198808183190702</ArticleId><ArticleId IdType="pmc">PMC3034374</ArticleId><ArticleId IdType="pubmed">3135496</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel KR, Bertuch A, Sasa GS, Himes RW, Wu H. Features of hepatitis in hepatitis-associated aplastic anemia: clinical and histopathologic study. J Pediatr Gastroenterol Nutr. (2017) 64:e7. doi: 10.1097/MPG.0000000000001271</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MPG.0000000000001271</ArticleId><ArticleId IdType="pubmed">28030425</ArticleId></ArticleIdList></Reference><Reference><Citation>Nastasio S, Mosca A, Alterio T, Sciveres M, Maggiore G. Juvenile autoimmune hepatitis: recent advances in diagnosis, management and long-term outcome. Diagnostics. (2023) 13:2753. doi: 10.3390/diagnostics13172753</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics13172753</ArticleId><ArticleId IdType="pmc">PMC10486972</ArticleId><ArticleId IdType="pubmed">37685291</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Casas R, Garcia-Buey L, Jones EA, Gisbert JP, Moreno-Otero R. Systematic review: hepatitis-associated aplastic anaemia–a syndrome associated with abnormal immunological function. Aliment Pharmacol Ther. (2009) 30:436–43. doi: 10.1111/j.1365-2036.2009.04060.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2036.2009.04060.x</ArticleId><ArticleId IdType="pubmed">19508613</ArticleId></ArticleIdList></Reference><Reference><Citation>Ben Hamza A, Welters C, Stadler S, Brüggemann M, Dietze K, Brauns O, et al. . Virus-reactive T cells expanded in aplastic anemia eliminate hematopoietic progenitor cells by molecular mimicry. Blood. (2024) 143:1365–78. doi: 10.1182/blood.2023023142</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2023023142</ArticleId><ArticleId IdType="pubmed">38277625</ArticleId></ArticleIdList></Reference><Reference><Citation>Osugi Y, Yagasaki H, Sako M, Kosaka Y, Taga T, Ito T, et al. . Antithymocyte globulin and cyclosporine for treatment of 44 children with hepatitis associated aplastic anemia. Haematologica. (2007) 92:1687–90. doi: 10.3324/haematol.11359</Citation><ArticleIdList><ArticleId IdType="doi">10.3324/haematol.11359</ArticleId><ArticleId IdType="pubmed">18055993</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorenz E, Quaiser K. [Panmyelopathy following epidemic hepatitis]. Wien Med Wochenschr 1946. (1955) 105:19–22.</Citation><ArticleIdList><ArticleId IdType="pubmed">14359977</ArticleId></ArticleIdList></Reference><Reference><Citation>Cattral MS, Langnas AN, Markin RS, Antonson DL, Heffron TG, Fox IJ, et al. . Aplastic anemia after liver transplantation for fulminant liver failure. Hepatol Baltim Md. (1994) 20:813–8. doi: 10.1002/(ISSN)1527-3350</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(ISSN)1527-3350</ArticleId><ArticleId IdType="pubmed">7927220</ArticleId></ArticleIdList></Reference><Reference><Citation>Pikis A, Kavaliotis J, Manios S. Incidence of aplastic anemia in viral hepatitis in children. Scand J Infect Dis. (1988) 20:109–10. doi: 10.3109/00365548809117226</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00365548809117226</ArticleId><ArticleId IdType="pubmed">3363300</ArticleId></ArticleIdList></Reference><Reference><Citation>Honkaniemi E, Gustafsson B, Fischler B, Nemeth A, Frost BM, Papadogiannakis N, et al. . Acquired aplastic anaemia in seven children with severe hepatitis with or without liver failure. Acta Paediatr. (2007) 96:1660–4. doi: 10.1111/j.1651-2227.2007.00491.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1651-2227.2007.00491.x</ArticleId><ArticleId IdType="pubmed">17888058</ArticleId></ArticleIdList></Reference><Reference><Citation>
World Health Organization . Disease outbreak news; acute hepatitis of unknown aetiology in children - multi-country (2022). Available online at: https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON400. (Accessed July 12, 2022).</Citation></Reference><Reference><Citation>
European Centre for Disease Prevention and Control . Joint ECDC-WHO regional office for europe weekly hepatitis of unknown origin in children surveillance bulletin . Available online at: https://www.ecdc.europa.eu/en/hepatitis/joint-hepatitis-unknown-origin-children-surveillance-bulletin.</Citation></Reference><Reference><Citation>
SPF . COVID-19 : point épidémiologique du 4 mars 2020 (2022). Available online at: https://www.santepubliqueFrance.fr/maladies-et-traumatismes/maladies-et-infections-respiratoires/infection-a-coronavirus/documents/bulletin-national/covid-19-point-epidemiologique-du-4-mars-2020.</Citation></Reference><Reference><Citation>Delehaye F, Habes D, Dourthe ME, Bertrand Y, Michel G, Gaudichon J, et al. . Management of childhood aplastic anemia following liver transplantation for nonviral hepatitis: A French survey. Pediatr Blood Cancer. (2020) 67:e28177. doi: 10.1002/pbc.28177</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pbc.28177</ArticleId><ArticleId IdType="pubmed">31925926</ArticleId></ArticleIdList></Reference><Reference><Citation>Balitzer D, Shafizadeh N, Peters MG, Ferrell LD, Alshak N, Kakar S. Autoimmune hepatitis: review of histologic features included in the simplified criteria proposed by the international autoimmune hepatitis group and proposal for new histologic criteria. Mod Pathol Off J U S Can Acad Pathol Inc. (2017) 30:773–83. doi: 10.1038/modpathol.2016.267</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/modpathol.2016.267</ArticleId><ArticleId IdType="pubmed">28106105</ArticleId></ArticleIdList></Reference><Reference><Citation>Kakuda Y, Harada K, Sawada-Kitamura S, Ikeda H, Sato Y, Sasaki M, et al. . Evaluation of a new histologic staging and grading system for primary biliary cirrhosis in comparison with classical systems. Hum Pathol. (2013) 44:1107–17. doi: 10.1016/j.humpath.2012.09.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humpath.2012.09.017</ArticleId><ArticleId IdType="pubmed">23313306</ArticleId></ArticleIdList></Reference><Reference><Citation>Killick SB, Bown N, Cavenagh J, Dokal I, Foukaneli T, Hill A, et al. . Guidelines for the diagnosis and management of adult aplastic anaemia. Br J Haematol. (2016) 172:187–207. doi: 10.1111/bjh.13853</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.13853</ArticleId><ArticleId IdType="pubmed">26568159</ArticleId></ArticleIdList></Reference><Reference><Citation>Brennan PN, Donnelly MC, Simpson KJ. Systematic review: non A-E, seronegative or indeterminate hepatitis; what is this deadly disease? Aliment Pharmacol Ther. (2018) 47:1079–91. doi: 10.1111/apt.14566</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apt.14566</ArticleId><ArticleId IdType="pubmed">29468698</ArticleId></ArticleIdList></Reference><Reference><Citation>Langnas AN, Markin RS, Cattral MS, Naides SJ. Parvovirus B19 as a possible causative agent of fulminant liver failure and associated aplastic anemia. Hepatol Baltim Md. (1995) 22:1661–5. doi: 10.1002/(ISSN)1527-3350</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(ISSN)1527-3350</ArticleId><ArticleId IdType="pubmed">7489971</ArticleId></ArticleIdList></Reference><Reference><Citation>Söderlund-Venermo M, Hokynar K, Nieminen J, Rautakorpi H, Hedman K. Persistence of human parvovirus B19 in human tissues. Pathol Biol. (2002) 50:307–16. doi: 10.1016/S0369-8114(02)00307-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0369-8114(02)00307-3</ArticleId><ArticleId IdType="pubmed">12116849</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander EC, Deep A. Characterization of a hepatitis outbreak in children, 2021 to 2022. JAMA Netw Open. (2022) 5:e2237091. doi: 10.1001/jamanetworkopen.2022.37091</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.37091</ArticleId><ArticleId IdType="pmc">PMC9579900</ArticleId><ArticleId IdType="pubmed">36255724</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho A, Orton R, Tayler R, Asamaphan P, Herder V, Davis C, et al. . Adeno-associated virus 2 infection in children with non-A–E hepatitis. Nature. (2023) 617:555–63. doi: 10.1038/s41586-023-05948-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-05948-2</ArticleId><ArticleId IdType="pubmed">36996873</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishiura H, Jung SM, Hayashi K. High population burden of Omicron variant (B.1.1.529) is associated with the emergence of severe hepatitis of unknown etiology in children. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. (2022) 122:30–2. doi: 10.1016/j.ijid.2022.05.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.05.028</ArticleId><ArticleId IdType="pmc">PMC9364819</ArticleId><ArticleId IdType="pubmed">35577248</ArticleId></ArticleIdList></Reference><Reference><Citation>Romaní Vidal A, Vaughan A, Innocenti F, Colombe S, Nerlander L, Rachwal N, et al. . Hepatitis of unknown aetiology in children - epidemiological overview of cases reported in Europe, 1 January to 16 June 2022. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull. (2022) 27:2200483. doi: 10.2807/1560-7917.ES.2022.27.31.2200483</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2022.27.31.2200483</ArticleId><ArticleId IdType="pmc">PMC9358403</ArticleId><ArticleId IdType="pubmed">35929429</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelgeri C, Couper M, Gupte GL, Brant A, Patel M, Johansen L, et al. . Clinical spectrum of children with acute hepatitis of unknown cause. N Engl J Med. (2022) 387:611–9. doi: 10.1056/NEJMoa2206704</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2206704</ArticleId><ArticleId IdType="pubmed">35830627</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong LYR, Perlman S. Immune dysregulation and immunopathology induced by SARS-CoV-2 and related coronaviruses — are we our own worst enemy? Nat Rev Immunol. (2022) 22:47–56. doi: 10.1038/s41577-021-00656-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00656-2</ArticleId><ArticleId IdType="pmc">PMC8617551</ArticleId><ArticleId IdType="pubmed">34837062</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundaresan B, Shirafkan F, Ripperger K, Rattay K. The role of viral infections in the onset of autoimmune diseases. Viruses. (2023) 15:782. doi: 10.3390/v15030782</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15030782</ArticleId><ArticleId IdType="pmc">PMC10051805</ArticleId><ArticleId IdType="pubmed">36992490</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Bastard P, Cobat A, Casanova JL. Human genetic and immunological determinants of critical COVID-19 pneumonia. Nature. (2022) 603:587–98. doi: 10.1038/s41586-022-04447-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04447-0</ArticleId><ArticleId IdType="pmc">PMC8957595</ArticleId><ArticleId IdType="pubmed">35090163</ArticleId></ArticleIdList></Reference><Reference><Citation>Pouletty M, Borocco C, Ouldali N, Caseris M, Basmaci R, Lachaume N, et al. . Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort. Ann Rheum Dis. (2020) 79:999–1006. doi: 10.1136/annrheumdis-2020-217960</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-217960</ArticleId><ArticleId IdType="pmc">PMC7299653</ArticleId><ArticleId IdType="pubmed">32527868</ArticleId></ArticleIdList></Reference><Reference><Citation>Toraih EA, Hussein MH, Elshazli RM, Kline A, Munshi R, Sultana N, et al. . Multisystem inflammatory syndrome in pediatric COVID-19 patients: a meta-analysis. World J Pediatr. (2021) 17:141–51. doi: 10.1007/s12519-021-00419-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12519-021-00419-y</ArticleId><ArticleId IdType="pmc">PMC7895741</ArticleId><ArticleId IdType="pubmed">33608839</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldstein LR, Rose EB, Horwitz SM, Collins JP, Newhams MM, Son MBF, et al. . Multisystem inflammatory syndrome in U.S. Children Adolescents. N Engl J Med. (2020) 383:334–46. doi: 10.1056/NEJMoa2021680</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2021680</ArticleId><ArticleId IdType="pmc">PMC7346765</ArticleId><ArticleId IdType="pubmed">32598831</ArticleId></ArticleIdList></Reference><Reference><Citation>Varchetta S, Mele D, Oliviero B, Mantovani S, Ludovisi S, Cerino A, et al. . Unique immunological profile in patients with COVID-19. Cell Mol Immunol. (2021) 18:604–12. doi: 10.1038/s41423-020-00557-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-00557-9</ArticleId><ArticleId IdType="pmc">PMC7557230</ArticleId><ArticleId IdType="pubmed">33060840</ArticleId></ArticleIdList></Reference><Reference><Citation>Muratori L, Lohse AW, Lenzi M. Diagnosis and management of autoimmune hepatitis. BMJ. (2023) 380:e070201. doi: 10.1136/bmj-2022-070201</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-070201</ArticleId><ArticleId IdType="pubmed">36746473</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng H, Zhang T, Xu Y, Lu X, Sang X. Autoimmune hepatitis after COVID-19 vaccination. Front Immunol. (2022) 13:1035073. doi: 10.3389/fimmu.2022.1035073</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1035073</ArticleId><ArticleId IdType="pmc">PMC9732229</ArticleId><ArticleId IdType="pubmed">36505482</ArticleId></ArticleIdList></Reference><Reference><Citation>Boettler T, Csernalabics B, Salié H, Luxenburger H, Wischer L, Salimi Alizei E, et al. . SARS-CoV-2 vaccination can elicit a CD8 T-cell dominant hepatitis. J Hepatol. (2022) 77:653–9. doi: 10.1016/j.jhep.2022.03.040</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2022.03.040</ArticleId><ArticleId IdType="pmc">PMC9021033</ArticleId><ArticleId IdType="pubmed">35461912</ArticleId></ArticleIdList></Reference><Reference><Citation>Avramescu M, Isnard P, Temmam S, Chevalier A, Bastard P, Attia M, et al. . Acute tubulointerstitial nephritis with or without uveitis: a novel form of post-acute COVID-19 syndrome in children. Kidney Int. (2023) 103:1193–8. doi: 10.1016/j.kint.2023.02.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2023.02.028</ArticleId><ArticleId IdType="pmc">PMC10008186</ArticleId><ArticleId IdType="pubmed">36918081</ArticleId></ArticleIdList></Reference><Reference><Citation>Leiskau C, Tsaka S, Meyer-Ruhnke L, Mutschler FE, Pfister ED, Lainka E, et al. . Acute severe non-A-E-hepatitis of unknown origin in children - A 30-year retrospective observational study from north-west Germany. J Hepatol. (2023) 78:971–8. doi: 10.1016/j.jhep.2022.12.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2022.12.012</ArticleId><ArticleId IdType="pubmed">36572350</ArticleId></ArticleIdList></Reference><Reference><Citation>McKenzie RB, Berquist WE, Nadeau KC, Louie CY, Chen SF, Sibley RK, et al. . Novel protocol including liver biopsy to identify and treat CD8+ T-cell predominant acute hepatitis and liver failure. Pediatr Transplant. (2014) 18:503–9. doi: 10.1111/petr.12296</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/petr.12296</ArticleId><ArticleId IdType="pubmed">24930635</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonnot M, Neumann F, Huet F, Maudinas R, Leblanc T, Lacaille F. Hepatitis-associated aplastic anemia. J Pediatr Gastroenterol Nutr. (2022) 75:553. doi: 10.1097/MPG.0000000000003603</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MPG.0000000000003603</ArticleId><ArticleId IdType="pubmed">36070526</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapin CA, Horslen SP, Squires JE, Lin H, Blondet N, Mohammad S, et al. . Corticosteroid therapy for indeterminate pediatric acute liver failure and aplastic anemia with acute hepatitis. J Pediatr. (2019) 208:23–9. doi: 10.1016/j.jpeds.2018.12.042</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2018.12.042</ArticleId><ArticleId IdType="pubmed">30770193</ArticleId></ArticleIdList></Reference><Reference><Citation>Muta T, Tanaka Y, Takeshita E, Kobayashi Y, Tokuyama T, Ueda Y, et al. . Recurrence of hepatitis-associated aplastic anemia after a 10-year interval. Intern Med Tokyo Jpn. (2008) 47:1733–7. doi: 10.2169/internalmedicine.47.0933</Citation><ArticleIdList><ArticleId IdType="doi">10.2169/internalmedicine.47.0933</ArticleId><ArticleId IdType="pubmed">18827426</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>